Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suppression of melanoma-associated neoangiogenesis by bevacizumab.
Jaissle GB, Ulmer A, Henke-Fahle S, Fierlbeck G, Bartz-Schmidt KU, Szurman P. Jaissle GB, et al. Among authors: henke fahle s. Arch Dermatol. 2008 Apr;144(4):525-7. doi: 10.1001/archdermatol.2007.38. Arch Dermatol. 2008. PMID: 18427047
Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.
Spitzer MS, Wallenfels-Thilo B, Sierra A, Yoeruek E, Peters S, Henke-Fahle S, Bartz-Schmidt KU, Szurman P; Tuebingen Bevacizumab Study Group. Spitzer MS, et al. Br J Ophthalmol. 2006 Oct;90(10):1316-21. doi: 10.1136/bjo.2006.095190. Epub 2006 May 24. Br J Ophthalmol. 2006. PMID: 16723358 Free PMC article.
Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
Yoeruek E, Ziemssen F, Henke-Fahle S, Tatar O, Tura A, Grisanti S, Bartz-Schmidt KU, Szurman P; Tübingen Bevacizumab Study Group. Yoeruek E, et al. Among authors: henke fahle s. Acta Ophthalmol. 2008 May;86(3):322-8. doi: 10.1111/j.1600-0420.2007.01049.x. Epub 2007 Nov 8. Acta Ophthalmol. 2008. PMID: 17995975 Free article.
Expression of endoglin in choroidal neovascularization.
Grisanti S, Canbek S, Kaiserling E, Adam A, Lafaut B, Gelisken F, Szurman P, Henke-Fahle S, Oficjalska-Mlynczak J, Bartz-Schmidt KU. Grisanti S, et al. Exp Eye Res. 2004 Feb;78(2):207-13. doi: 10.1016/j.exer.2003.11.008. Exp Eye Res. 2004. PMID: 14729353
The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute.
Schramm C, Spitzer MS, Henke-Fahle S, Steinmetz G, Januschowski K, Heiduschka P, Geis-Gerstorfer J, Biedermann T, Bartz-Schmidt KU, Szurman P. Schramm C, et al. Among authors: henke fahle s. Invest Ophthalmol Vis Sci. 2012 Feb 2;53(2):613-21. doi: 10.1167/iovs.11-7322. Invest Ophthalmol Vis Sci. 2012. PMID: 22199245
GDF-15: a novel serum marker for metastases in uveal melanoma patients.
Suesskind D, Schatz A, Schnichels S, Coupland SE, Lake SL, Wissinger B, Bartz-Schmidt KU, Henke-Fahle S. Suesskind D, et al. Among authors: henke fahle s. Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):887-95. doi: 10.1007/s00417-011-1786-6. Epub 2011 Sep 1. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 21881845
40 results